Diminished neo-antigen response to keyhole limpet hemocyanin (KLH) vaccines in patients after treatment with chemotherapy or hematopoietic cell transplantation

Clinical Immunology

Volumn 117, Issue 2, 2005, Pages 144-151

  Miller, Jeffrey S ^a   Curtsinger, Julie ^a   Berthold, Melinda ^a   Malvey, Kirsten ^a   Bliss, Robin L ^a   Le, Chap T ^a   Fautsch, Susan K ^a   Dudek, Arkadiusz Z ^a   Blazar, Bruce R ^a   Panoskaltsis Mortari, Angela ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

Author keywords

Cancer; Cellular response; Hematopoietic cell transplantation; Humoral response; Immune defect; Immune response; Neo antigen; Vaccines

Indexed keywords

ADJUVANT; ANTIGEN; INTRACEL; KEYHOLE LIMPET HEMOCYANIN;

ARTICLE; CANCER PATIENT; CANCER STAGING; CELL TRANSPLANTATION; CHEMOTHERAPY; CLINICAL ARTICLE; DRUG SAFETY; HEMATOPOIETIC CELL; HUMAN; HUMORAL IMMUNITY; IMMUNE RESPONSE; MEASUREMENT; MOLECULAR WEIGHT; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; VACCINATION; VOLUNTEER;

BIOLOGICAL MARKERS; CANCER VACCINES; CD4-POSITIVE T-LYMPHOCYTES; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEMOCYANIN; HUMANS; IMMUNOGLOBULINS; NEOPLASMS; RECURRENCE;

EID: 26044473580     PISSN: 15216616     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clim.2005.07.005     Document Type: Article

References (45)

1. S. Brkic, M.S. Tsoi, T. Mori, L. Lachman, S. Gillis, E.D. Thomas, and R. Storb Cellular interactions in marrow-grafted patients: III. Normal interleukin 1 and defective interleukin 2 production in short-term patients and in those with chronic graft-versus-host disease Transplantation 39 1985 30 35
2. E. Bolotin, M. Smogorzewska, S. Smith, M. Widmer, and K. Weinberg Enhancement of thymopoiesis after bone marrow transplant by in vivo interleukin-7 Blood 88 1996 1887 1894
3. E. Bolotin, G. Annett, R. Parkman, and K. Weinberg Serum levels of IL-7 in bone marrow transplant recipients: relationship to clinical characteristics and lymphocyte count Bone Marrow Transplant. 23 1999 783 788
4. C.L. Mackall, D. Stein, T.A. Fleisher, M.R. Brown, F.T. Hakim, C.V. Bare, S.F. Leitman, E.J. Read, C.S. Carter, L.H. Wexler, and R.E. Gress Prolonged CD4 depletion after sequential autologous peripheral blood progenitor cell infusions in children and young adults Blood 96 2000 754 762
5. D. Avigan, Z. Wu, R. Joyce, A. Elias, P. Richardson, D. McDermott, J. Levine, L. Kennedy, N. Giallombardo, D. Hurley, J. Gong, and D. Kufe Immune reconstitution following high-dose chemotherapy with stem cell rescue in patients with advanced breast cancer Bone Marrow Transplant. 26 2000 169 176
6. J. Storek, M.A. Dawson, B. Storer, T. Stevens-Ayers, D.G. Maloney, K.A. Marr, R.P. Witherspoon, W. Bensinger, M.E. Flowers, P. Martin, R. Storb, F.R. Appelbaum, and M. Boeckh Immune reconstitution after allogeneic marrow transplantation compared with blood stem cell transplantation Blood 97 2001 3380 3389
7. M. Maris, M. Boeckh, B. Storer, M. Dawson, K. White, M. Keng, B. Sandmaier, D. Maloney, R. Storb, and J. Storek Immunologic recovery after hematopoietic cell transplantation with nonmyeloablative conditioning Exp. Hematol. 31 2003 941 952
8. E.C. Guinan, D.C. Molrine, J.H. Antin, M.C. Lee, H.J. Weinstein, S.E. Sallan, S.K. Parsons, C. Wheeler, W. Gross, and C. McGarigle Polysaccharide conjugate vaccine responses in bone marrow transplant patients Transplantation 57 1994 677 684
9. R.P. Witherspoon, R. Storb, H.D. Ochs, N. Fluornoy, K.J. Kopecky, K.M. Sullivan, J.H. Deeg, R. Sosa, D.R. Noel, K. Atkinson, and E.D. Thomas Recovery of antibody production in human allogeneic marrow graft recipients: influence of time posttransplantation, the presence or absence of chronic graft-versus-host disease, and antithymocyte globulin treatment Blood 58 1981 360 368
10. B.L. Hamilton, and H.D. Ochs Immune dysfunction associated with graft-versus-host reaction in mice transplanted across minor histocompatibility barriers. I. Depressed antigen-specific antibody responses to bacteriophage phi chi 174 Transplantation 47 1989 1061 1067
11. I. Fogelman, V. Davey, H.D. Ochs, M. Elashoff, M.B. Feinberg, J. Mican, J.P. Siegel, M. Sneller, and H.C. Lane Evaluation of CD4+ T cell function in vivo in HIV-infected patients as measured by bacteriophage phiX174 immunization J. Infect. Dis. 182 2000 435 441
12. R.G. Andrews, A. Winkler, J. Potter, E. Bryant, G.H. Knitter, I.D. Bernstein, and H.D. Ochs Normal immunologic response to a neoantigen, bacteriophage phiX-174, in baboons with long-term lymphohematopoietic reconstitution from highly purified CD34+ Lin- allogeneic marrow cells Blood 90 1997 1701 1708
13. L.W. Kwak, H.A. Young, R.W. Pennington, and S.D. Weeks Vaccination with syngeneic, lymphoma-derived immunoglobulin idiotype combined with granulocyte/macrophage colony-stimulating factor primes mice for a protective T-cell response Proc. Natl. Acad. Sci. U. S. A. 93 1996 10972 10977
14. S.S. Neelapu, S. Baskar, and L.W. Kwak Detection of keyhole limpet hemocyanin (KLH)-specific immune responses by intracellular cytokine assay in patients vaccinated with idiotype-KLH vaccine J. Cancer Res. Clin. Oncol. 127 Suppl. 2 2001 R14 R19
15. C.T. Le, P.M. Grambsch, and G.S. Giebink Quality control and the identification of vaccine responders using ELISA-derived antibody data Stat. Med. 22 2003 2935 2942
16. D.J. Sheskin, Handbook of parametric and nonparametric statistical procedures, 2nd ed. Test 281: The Partial Correlation, Chapman and Hall/CRC, 2000, pp.819-821.
17. V. Rubio, T.B. Stuge, N. Singh, M.R. Betts, J.S. Weber, M. Roederer, and P.P. Lee Ex vivo identification, isolation and analysis of tumor-cytolytic T cells Nat. Med. 9 2003 1377 1382
18. P.P. Lee, C. Yee, P.A. Savage, L. Fong, D. Brockstedt, J.S. Weber, D. Johnson, S. Swetter, J. Thompson, P.D. Greenberg, M. Roederer, and M.M. Davis Characterization of circulating T cells specific for tumor-associated antigens in melanoma patients Nat. Med. 5 1999 677 685
19. R. Kass, S. Bellone, M. Palmieri, S. Cane, E. Bignotti, R. Henry-Tillman, L. Hutchins, M.J. Cannon, S. Klimberg, and A.D. Santin Restoration of tumor-specific HLA class I restricted cytotoxicity in tumor infiltrating lymphocytes of advanced breast cancer patients by in vitro stimulation with tumor antigen-pulsed autologous dendritic cells Breast Cancer Res. Treat. 80 2003 275 285
20. R.M. Wolfram, A.C. Budinsky, T. Brodowicz, M. Kubista, W.J. Kostler, C. Kichler-Lakomy, M. Hellan, G. Kahlhammer, C. Wiltschke, and C.C. Zielinski Defective antigen presentation resulting from impaired expression of costimulatory molecules in breast cancer Int. J. Cancer 88 2000 239 244
21. I. Caras, A. Grigorescu, C. Stavaru, D.L. Radu, I. Mogos, G. Szegli, and A. Salageanu Evidence for immune defects in breast and lung cancer patients Cancer Immunol. Immunother. 53 2004 1146 1152
22. S. Zanussi, E. Vaccher, C. Caffau, C. Pratesi, C. Crepaldi, M.T. Bortolin, R. Tedeschi, D. Politi, L. Barzan, U. Tirelli, and P. De Paoli Interferon-gamma secretion and perforin expression are impaired in CD8+ T lymphocytes from patients with undifferentiated carcinoma of nasopharyngeal type Cancer Immunol. Immunother. 52 2003 28 32
23. D.I. Gabrilovich, J. Corak, I.F. Ciernik, D. Kavanaugh, and D.P. Carbone Decreased antigen presentation by dendritic cells in patients with breast cancer Clin. Cancer Res. 3 1997 483 490
24. B. Almand, J.R. Resser, B. Lindman, S. Nadaf, J.I. Clark, E.D. Kwon, D.P. Carbone, and D.I. Gabrilovich Clinical significance of defective dendritic cell differentiation in cancer Clin. Cancer Res. 6 2000 1755 1766
25. J.E. Ohm, D.I. Gabrilovich, G.D. Sempowski, E. Kisseleva, K.S. Parman, S. Nadaf, and D.P. Carbone VEGF inhibits T-cell development and may contribute to tumor-induced immune suppression Blood 101 2003 4878 4886
26. J.E. Ohm, and D.P. Carbone VEGF as a mediator of tumor-associated immunodeficiency Immunol. Res. 23 2001 263 272
27. S. Kusmartsev, and D.I. Gabrilovich Immature myeloid cells and cancer-associated immune suppression Cancer Immunol. Immunother. 51 2002 293 298
28. S. Kusmartsev, Y. Nefedova, D. Yoder, and D.I. Gabrilovich Antigen-specific inhibition of CD8+ T cell response by immature myeloid cells in cancer is mediated by reactive oxygen species J. Immunol. 172 2004 989 999
29. B. Almand, J.I. Clark, E. Nikitina, J. van Beynen, N.R. English, S.C. Knight, D.P. Carbone, and D.I. Gabrilovich Increased production of immature myeloid cells in cancer patients: a mechanism of immunosuppression in cancer J. Immunol. 166 2001 678 689
30. P. Chaux, M. Moutet, J. Faivre, F. Martin, and M. Martin Inflammatory cells infiltrating human colorectal carcinomas express HLA class II but not B7-1 and B7-2 costimulatory molecules of the T-cell activation Lab. Invest. 74 1996 975 983
31. D.H. Munn, M.D. Sharma, J.R. Lee, K.G. Jhaver, T.S. Johnson, D.B. Keskin, B. Marshall, P. Chandler, S.J. Antonia, R. Burgess, C.L. Slingluff Jr., and A.L. Mellor Potential regulatory function of human dendritic cells expressing indoleamine 2,3-dioxygenase Science 297 2002 1867 1870
32. M.L. Chen, M.J. Pittet, L. Gorelik, R.A. Flavell, R. Weissleder, H. von Boehmer, and K. Khazaie Regulatory T cells suppress tumor-specific CD8 T cell cytotoxicity through TGF-beta signals in vivo Proc. Natl. Acad. Sci. U. S. A. 102 2005 419 424
33. L.A. Ormandy, T. Hillemann, H. Wedemeyer, M.P. Manns, T.F. Greten, and F. Korangy Increased populations of regulatory T cells in peripheral blood of patients with hepatocellular carcinoma Cancer Res. 65 2005 2457 2464
34. M. Gerloni, and M. Zanetti CD4 T cells in tumor immunity Springer Semin. Immunopathol. 27 2005 37 48
35. H. Kawaida, K. Kono, A. Takahashi, H. Sugai, K. Mimura, N. Miyagawa, H. Omata, A. Ooi, and H. Fujii Distribution of CD4+CD25 high regulatory T-cells in tumor-draining lymph nodes in patients with gastric cancer J. Surg. Res. 124 2005 151 157
36. T.J. Curiel, G. Coukos, L. Zou, X. Alvarez, P. Cheng, P. Mottram, M. Evdemon-Hogan, J.R. Conejo-Garcia, L. Zhang, M. Burow, Y. Zhu, S. Wei, I. Kryczek, B. Daniel, A. Gordon, L. Myers, A. Lackner, M.L. Disis, K.L. Knutson, L. Chen, and W. Zou Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival Nat. Med. 10 2004 942 949
37. M. Viguier, F. Lemaitre, O. Verola, M.S. Cho, G. Gorochov, L. Dubertret, H. Bachelez, P. Kourilsky, and L. Ferradini Foxp3 expressing CD4+CD25 (high) regulatory T cells are overrepresented in human metastatic melanoma lymph nodes and inhibit the function of infiltrating T cells J. Immunol. 173 2004 1444 1453
38. M. Yamagami, P.W. McFadden, S.M. Koethe, V. Ratanatharathorn, and L.G. Lum Failure of T cell receptor-anti-CD3 monoclonal antibody interaction in T cells from marrow recipients to induce increases in intracellular ionized calcium J. Clin. Invest. 86 1990 1347 1351
39. K. Atkinson Reconstruction of the hematopoietic and immune systems after marrow transplantation Bone Marrow Transplant. 5 1990 209 226
40. L.G. Lum The kinetics of immune reconstitution after human marrow transplantation Blood 69 1987 369 380
41. R. Parkman, and K.I. Weinberg Hematopoietic Cell Transplantation 1998 Blackwell Science Inc. Malden
42. V.L. Reichardt, C.Y. Okada, A. Liso, C.J. Benike, K.E. Stockerl-Goldstein, E.G. Engleman, K.G. Blume, and R. Levy Idiotype vaccination using dendritic cells after autologous peripheral blood stem cell transplantation for multiple myeloma-A feasibility study Blood 93 1999 2411 2419
43. A. Liso, K.E. Stockerl-Goldstein, S. Auffermann-Gretzinger, C.J. Benike, V. Reichardt, A. van Beckhoven, R. Rajapaksa, E.G. Engleman, K.G. Blume, and R. Levy Idiotype vaccination using dendritic cells after autologous peripheral blood progenitor cell transplantation for multiple myeloma Biol. Blood Marrow Transplant. 6 2000 621 627
44. D.C. Douek, R.A. Vescio, M.R. Betts, J.M. Brenchley, B.J. Hill, L. Zhang, J.R. Berenson, R.H. Collins, and R.A. Koup Assessment of thymic output in adults after haematopoietic stem-cell transplantation and prediction of T-cell reconstitution Lancet 355 2000 1875 1881
45. C.L. Mackall, T.A. Fleisher, M.R. Brown, M.P. Andrich, C.C. Chen, I.M. Feuerstein, M.E. Horowitz, I.T. Magrath, A.T. Shad, and S.M. Steinberg Age, thymopoiesis, and CD4+ T-lymphocyte regeneration after intensive chemotherapy N. Engl. J. Med. 332 1995 143 149